TherapeuticsMD Files Definitive Proxy Statement
Ticker: TXMD · Form: DEF 14A · Filed: Oct 25, 2024 · CIK: 25743
Sentiment: neutral
Topics: proxy-statement, corporate-governance
Related Tickers: TXMD
TL;DR
TXMD proxy filing is out - get ready to vote on company matters.
AI Summary
TherapeuticsMD, Inc. filed a Definitive Proxy Statement (DEF 14A) on October 25, 2024, for its fiscal year ending December 31, 2024. The filing, which is a proxy statement, is related to the company's corporate governance and shareholder matters. TherapeuticsMD, Inc. is a pharmaceutical preparations company incorporated in Nevada.
Why It Matters
This filing provides shareholders with essential information regarding upcoming shareholder meetings, voting procedures, and company governance, allowing them to make informed decisions.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing, which is standard for public companies and does not inherently indicate new risks.
Key Players & Entities
- TherapeuticsMD, Inc. (company) — Registrant
- 0001213900-24-090849 (filing_id) — Accession Number
- 20241025 (date) — Filing Date
- 20241205 (date) — Period of Report
- NV (state) — State of Incorporation
- BOCA RATON (city) — Business Address City
- FL (state) — Business Address State
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing is a Definitive Proxy Statement filed by a company to provide shareholders with information about matters to be voted on at an upcoming shareholder meeting, such as director elections, executive compensation, and other corporate actions.
When was this DEF 14A filed by TherapeuticsMD, Inc.?
This DEF 14A filing was filed on October 25, 2024.
What is the fiscal year end for TherapeuticsMD, Inc.?
The fiscal year end for TherapeuticsMD, Inc. is December 31.
What is the Standard Industrial Classification (SIC) code for TherapeuticsMD, Inc.?
The SIC code for TherapeuticsMD, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Where is TherapeuticsMD, Inc. headquartered?
TherapeuticsMD, Inc. is headquartered in Boca Raton, Florida.
Filing Stats: 4,383 words · 18 min read · ~15 pages · Grade level 14 · Accepted 2024-10-25 17:00:39
Filing Documents
- ea0217586-01.htm (DEF 14A) — 1165KB
- ttherapeuticsmd_logo.jpg (GRAPHIC) — 38KB
- tmarlan_sig.jpg (GRAPHIC) — 14KB
- timage_001.jpg (GRAPHIC) — 21KB
- timage_002.jpg (GRAPHIC) — 12KB
- timage_003.jpg (GRAPHIC) — 21KB
- tbarchart_001.jpg (GRAPHIC) — 535KB
- tbarchart_002.jpg (GRAPHIC) — 543KB
- tproxy_001.jpg (GRAPHIC) — 1454KB
- tproxy_002.jpg (GRAPHIC) — 865KB
- 0001213900-24-090849.txt ( ) — 5992KB
Security Ownership of Principal Stockholders, Directors, and Officer s
Security Ownership of Principal Stockholders, Directors, and Officer s 31 Proposal Two: Advisory Vote on Executive Compensation (“Say-on-Pay” ) 32 Proposal Three: Ratification of Appointment of Independent Audito r 33 Deadline For Receipt of Stockholder Proposal s 35 Householding of Proxy Material s 35 Other Matter s 35 Where You Can Find Additional Information and Incorporation by Referenc e 36 2   Table of Contents PROXY SUMMAR Y This summary highlights information contained elsewhere in the Proxy Statement. This summary does not contain all of the information you should consider. Please read the entire Proxy Statement carefully before voting. 2024 Annual Meeting of Stockholders     Date and Time: December 5, 2024 8:00 am Eastern Time   Place: Online via live webcast at: www.proxydocs.com / TXMD   Record Date: October 17, 2024 Items of Business: •     To elect directors to serve until our next annual meeting of stockholders or until their successors are duly elected and qualified; •     To approve, on a non -binding advisory basis, the compensation of our named executive officers for the fiscal year ended December   31, 2023 (“say -on -pay ”); •     To ratify the appointment of Berkowitz Pollack Brant Advisors + CPAs, LLP (“Berkowitz Pollack Brant”), an independent registered public accounting firm, as the independent auditor of our Company for the fiscal year ending December   31, 2024; and •     To transact such other business as may properly come before the meeting or any adjournment thereof. 3       Table of Contents THERAPEUTICSMD, INC. 951 Yamato Road, Suite 220 Boca Raton, Florida 33431 PROXY STATEMENT VOTING AND OTHER MATTERS